High-dose biotin appears to be ineffective and potentially harmful in the treatment of progressive multiple sclerosis (MS), contradicting an earlier study. A randomized trial from The Lancet of over 600 participants with MS found those who took 100 mg of biotin three times per day (10,000 times higher than the RDA) or placebo failed to…
Episode 79: Dr. Terry Wahls on how The Wahls Protocol came to be, and How to Launch Your Own Clinical Research Trial
We are all familiar with the Wahls Protocol. But how about the story behind the protocol? Did you know, for instance, that her director at U of Iowa (Terry is a clinician-researcher) told her to write up herself as a case report? That was the first step. Her “N of 1”; then she wrote up a case series. Then she received a small grant and product for a slightly larger study. Then a million dollars. And now she’s heading into her largest study to date (yes, you will be able to refer patients). Listen to our New Frontiers conversation on how YOU as a FxMed clinician can contribute to the body of research demonstrating that: What. We. Do. Works.
Dr. Goodenowe invented a technology platform in 1999 that has been used to analyze thousands of human samples from around the world. Through collaborations with international researchers and doctors, Dr. Goodenowe has become an expert on the biochemical basis of neurological diseases including Alzheimer’s, Parkinson’s, multiple sclerosis, autism, bipolar disorder, and schizophrenia. Prodrome Sciences uses Dr. Goodenowe’s technology and discoveries to develop blood tests and dietary supplements for the early detection and prevention of disease.
In recent years, mast cell diseases have become a hot topic in functional medicine and Dr. Theoharis Theoharides has been at the forefront of the research on mast cells. He was the first to show that mast cells are involved in a wide range of allergic reactions and inflammatory conditions, including allergies, asthma, eczema, psoriasis, migraines, multiple sclerosis.
Dr. Terry Wahls was a practicing primary care physician when she was diagnosed with relapsing-remitting MS. Despite treatment at some of the finest medical institutions in the United States, her health progressively declined until she could no longer walk. When she discovered functional medicine, she made a rapid turnaround.